Edition:
United Kingdom

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

2.01USD
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
25,481
52-wk High
$10.35
52-wk Low
$2.01

Chart for

About

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in... (more)

Overall

Beta: --
Market Cap(Mil.): $169.25
Shares Outstanding(Mil.): 16.82
Dividend: --
Yield (%): --

Financials

  OBLN.OQ Industry Sector
P/E (TTM): -- 32.18 32.76
EPS (TTM): -1.69 -- --
ROI: -75.69 13.91 14.61
ROE: -- 16.75 16.34

BRIEF-Obalon Therapeutics Q4 Loss Per Share $0.60

* OBALON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

05 Mar 2018

BRIEF-Obalon Therapeutics Says Audit Committee's Investigation Into Purported Whistleblower Complaint Concluded Allegations Are Meritless

* OBALON THERAPEUTICS - AUDIT COMMITTEE COMPLETED INVESTIGATION INTO PURPORTED WHISTLEBLOWER COMPLAINT; CONCLUDED ALLEGATIONS ARE MERITLESS

20 Feb 2018

Obalon cancels offering after allegation on accounting practices

Jan 23 Obalon Therapeutics Inc said on Tuesday it canceled a stock offering after the medical device maker, known for its swallowable balloons that aid in weight loss, was accused of improper accounting practices.

23 Jan 2018

BRIEF-Obalon Therapeutics prices offering of 5.5 mln shares at $5.50 per share

* OBALON THERAPEUTICS INC - ‍PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 5.5 MILLION SHARES OF COMMON STOCK AT A OFFERING PRICE OF $5.50 PER SHARE​ Source text for Eikon: Further company coverage:

19 Jan 2018

Earnings vs. Estimates